146 papers
Understanding the human mind and treating mental health conditions requires a deep blend of biological insight and behavioral science. This category explores the cutting-edge research shaping how we diagnose and treat psychiatric disorders, from depression and anxiety to complex neurological conditions. Here, you will find the latest discoveries that bridge the gap between clinical observation and molecular mechanisms, offering fresh perspectives on patient care and therapeutic innovation.
Gist.Science brings these vital studies directly to you by monitoring medRxiv, the leading preprint server for health sciences. As soon as new manuscripts appear in this field, our team processes them to provide both accessible plain-language summaries and detailed technical overviews. This ensures that complex findings are understandable for everyone, from curious readers to busy professionals who need quick, accurate insights without wading through dense academic prose.
Below are the most recent psychiatry and clinical psychology preprints, curated and summarized to keep you informed on the evolving landscape of mental health research.
This study integrates multiple genomic approaches to identify that genetic variations in transfer RNA modification enzymes, particularly NSUN2, significantly contribute to the risk of Bipolar I Disorder and Schizophrenia by dysregulating RNA modification machinery.
This study demonstrates that analyzing transient spectral events (SEF) in resting-state EEG, particularly frontopolar beta duration, alongside traditional averaged power features, improves the prediction of antidepressant response to sertraline and identifies shorter baseline beta events as a potential cross-modal biomarker for treatment readiness.
This observational, transdiagnostic study protocol outlines a plan to recruit 300 participants across five diagnostic groups to investigate the neurobiological, neurocognitive, and electrophysiological correlates of negative symptoms, with a specific focus on avolition, in order to identify biomarkers that can guide the development of improved assessment tools and therapeutic strategies for serious mental illness.
This study demonstrates that the myHealthE digital platform successfully engaged over 10,000 families in South London's child and adolescent mental health services, significantly streamlining routine outcome data collection, resource access, and research recruitment compared to traditional methods.
This single-group feasibility trial demonstrates that a therapist-guided, internet-delivered trauma-focused CBT program is safe, acceptable, and associated with clinically meaningful reductions in PTSD symptoms among adolescents, supporting the need for further efficacy trials.
This study demonstrates that schizophrenia spectrum disorders are characterized by pervasive, trait-like interoceptive disturbances, including impaired subjective bodily regulation, marginally reduced accuracy, and attenuated neural processing of cardiac signals, which are most consistently linked to depersonalization symptoms.